ICP 2024 – ZenoWell cofounder Presents Breakthrough Research on ASD and Neuroimaging
Date: July 21 – 26, 2024
Location: O₂ universum，Prague, Czech Republic
At the 33rd International Congress of Psychology (ICP 2024), held once every four years and recognized as one of the most prestigious gatherings in the field of psychology, ZenoWell co-founder Dr. Shaw was invited to present her latest research on neuroimaging-based intervention strategies for children with Autism Spectrum Disorder (ASD).
Her presentation focused on the use of advanced neuroimaging and neural decoding techniques to better understand the cognitive and neural signatures of ASD, and how these tools can support personalized interventions in early development.
The session drew attention from both clinicians and researchers, offering insights into the potential of non-invasive brain technologies to accelerate therapeutic innovation in neurodevelopmental disorders.
ZenoWell remains committed to pushing the frontiers of psychological science, cognitive neuroscience, and neuromodulation, integrating research and technology to make mental health support more precise, accessible, and effective.
Tags:
Previous post
CES 2025 – ZenoWell Showcases the Future of Wearable Neurotechnology
Next post
Stanford GMIX Project Group Visit ZenoWell
Related Posts
Supporting Long-Term Care in Chronic Gastrointestinal Health
Event: 3rd Annual Virtual Gastroparesis ConferenceHost: G-PACT (Gastroparesis Patient Association for Cures and Treatments)Date: March 21, 2026Time: 10:00 am – 2:00 pm (EST)Format: Online...
Mar 06 2026
ZenoWell Founder Presents on Vagus Nerve Regulation and Neurofeedback at ACAN 2026
Date: June 5–6, 2026Location: Opatija, CroatiaEvent: 4th Annual Conference for Applied Neurofeedback (ACAN 2026)Official Conference Website: https://www.acan.beemedic.com/content ZenoWell’s founder was invited to speak at...
Mar 04 2026
Stanford GMIX Project Group Visit ZenoWell
Date: August 19, 2025 Location: ZenoWell Innovation Center Overview A Stanford GMIX (Global Management Immersion Experience) student group with backgrounds in Biomedical Engineering, Medicine,...
Sep 23 2025
CES 2025 – ZenoWell Showcases the Future of Wearable Neurotechnology
Date: January 9–12, 2025 Location: Digital Health Pavilion, CES, Las Vegas Convention Center, Las Vegas, USA ZenoWell made its official debut at CES 2025,...
Jul 25 2025
OHBM 2025 – ZenoWell Presents Breakthrough Research on taVNS and Brain Modulation
Date: June 23–27, 2025 Location: Brisbane Convention & Exhibition Centre, Brisbane, Australia At the Annual Meeting of the Organization for Human Brain Mapping (OHBM)...
Jul 25 2025
IFA 2025 – ZenoWell to Unveil the Future of Wearable Neurotech in Berlin
Date: September 5–9, 2025 Location: Messe Berlin, Berlin, Germany Exhibition Area: IFA Health & Wellness Tech Pavilion Registration Link: https://ifa-berlin-2025.reg.buzz/ ZenoWell is excited to...
Jul 25 2025
CES 2026 – ZenoWell Returns to Las Vegas with Cutting-Edge taVNS Innovations
Date: January 6–9, 2026 Location: Las Vegas Convention Center, Las Vegas, USA Exhibition Area: Venetian Expo, Halls A-D, Digital Health Pavilion, Booth 55732 Award Entry:...
Jul 25 2025
